<DOC>
	<DOCNO>NCT01801124</DOCNO>
	<brief_summary>Phase 4 study evaluate effectiveness EXPAREL infiltrate Transversus Abdominis Plane ( TAP ) .</brief_summary>
	<brief_title>EXPAREL Infiltrated Into TAP Postoperative Analgesia Unilateral Abdominal Hernia Repair</brief_title>
	<detailed_description>This prospective , open-label , non-randomized study evaluate effectiveness abdominal analgesia use 266 mg EXPAREL infiltrate TAP unilaterally .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Abdominal</mesh_term>
	<criteria>Males female , age 1875 year inclusive , ASA physical status 13 . Undergoing open repair unilateral abdominal hernia level umbilicus . Abdominal incision length 312 cm . Subjects must physically mentally able participate study complete study assessment . Subjects must able give fully inform consent participate study demonstrate good understanding risk benefit propose component TAP infiltration . History hypersensitivity idiosyncratic reaction amidetype local anesthetic Any subject whose anatomy , surgical procedure , opinion Investigator , might preclude potential successful performance TAP infiltration . Any subject opinion Investigator , might harm poor candidate participation study . Any subject , opinion Investigator , chronic pain medicine . Any female subject currently pregnant . Subjects receive investigational drug within 30 day prior study drug administration , plan administration another investigational product procedure participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>analgesia</keyword>
	<keyword>hernia repair</keyword>
</DOC>